MAOA Gene: Monoamine Oxidase A

Genetic and Functional Insights into MAOA

Gene Information Card

Symbol MAOA
Full Name Monoamine Oxidase A
Gene Type protein-coding
Chromosomal Location Xp11.3
NCBI Gene ID 4128 ncbi.nlm.nih.gov/gene/4128
Ensembl ID ENSG00000189221
UniProt ID P21397
OMIM ID 309850
HGNC ID 6833
Aliases MAO-A, MGC26582

Description

The MAOA gene encodes monoamine oxidase A, a mitochondrial enzyme that catalyzes the oxidative deamination of neurotransmitters such as serotonin, norepinephrine, and dopamine. It plays a critical role in the regulation of neurotransmitter levels and is implicated in neuropsychiatric disorders and behavioral traits.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Brunner syndrome Loss-of-function mutations in MAOA lead to impaired degradation of monoamines, resulting in elevated serotonin and norepinephrine levels, associated with impulsive aggression and intellectual disability. OMIM #300615; ClinVar
Major depressive disorder Altered MAOA activity influences monoamine neurotransmitter availability; elevated MAOA expression is linked to depressive symptoms. NCBI Gene; PubMed
Parkinson's disease MAOA contributes to oxidative stress via dopamine metabolism; genetic variants may modulate risk. OMIM; COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 High
Brain (cortex) 8.3 Medium
Heart 4.1 Low
Kidney 3.7 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 9.2 Neuronal model
HepG2 (hepatocellular carcinoma) 11.8 High expression
HEK293 (embryonic kidney) 2.5 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.878C>T (p.Pro293Leu) Missense Rare Loss of function; associated with Brunner syndrome
c.892G>A (p.Gly298Arg) Missense <0.01% Reduced enzyme activity
c.1460C>T (p.Thr487Ile) Missense 0.02% Altered substrate specificity
Mutation functional classification

Loss of Function (LOF)

Missense mutations (e.g., p.Pro293Leu) reduce or abolish catalytic activity, leading to monoamine accumulation and Brunner syndrome.

Gain of Function (GOF)

Not well documented; some variants may increase activity but are not clinically established.

Dominant Negative (DN)

Not reported for MAOA; the gene is X-linked, and hemizygous males are primarily affected.

Gene Ontology (GO)

• GO:0008131 – primary amine oxidase activity • GO:0005739 – mitochondrion
• GO:0006584 – catecholamine metabolic process • GO:0042420 – dopamine catabolic process
• GO:0055114 – oxidation-reduction process

Pathways

REACT:111217 – Metabolism of serotonin
REACT:111219 – Dopamine degradation
REACT:111221 – Norepinephrine degradation

Protein Summary

Monoamine oxidase A (MAOA) is a 527-amino acid mitochondrial outer membrane flavoenzyme. It exists as a homodimer and uses FAD as a cofactor to deaminate biogenic amines. The protein is highly expressed in the liver and brain, where it regulates neurotransmitter turnover. Structural studies reveal a hydrophobic substrate-binding cavity that determines specificity for serotonin and norepinephrine.

Related Products

Product name Cat.No. Species Gene ID
MAOA Knockout HEK293T Cell Line EDJ-KQ219 Human 4128 Details Get a Quote
MAOA Knockout HEK293 Cell Line EDJ-KQ2873 Human 4128 Details Get a Quote
MAOA Knockout A-549 Cell Line EDJ-KQ25292 Human 4128 Details Get a Quote
MAOA Knockout HCT 116 Cell Line EDJ-KQ25294 Human 4128 Details Get a Quote
MAOA Knockout HeLa Cell Line EDJ-KQ25295 Human 4128 Details Get a Quote
MAOA Knockout HAP1 Cell Line EDC08260 Human 4128 Details Get a Quote
Displaying Records 1 To 6 Of 6 Records
Contact Us
*
*
*
*
How did you hear about us: